These innovative therapies , Tirzepatide , represent a significant advancement in managing obesity and potentially related disorders. They are categorized as GLP-1 receptor stimulators, meaning they to emulate the body's GLP-1 substance , enhancing insulin release and lowering food intake. Despite Tirzepatide each functions largely similarly, they